Commentary: the use of maximum tolerated dose in rodent carcinogenicity bioassays and its relevance to human risk assessment

Abstract

Get full access to this article

View all access options for this article.

References

McConnel EE The maximum tolerated dose: The debate. J Am Coll Toxicol 1989; 8: 115 -20.

Goldstein BD Rick assessment methodology: Maximum tolerated dose and two-stage carcinogenesis models. Toxicol Path 1994; 22: 194-7.

Ames BN , Gold LS Too many rodent carcinogens: Mitogenesis increses mitogenesis. Science 1990; 249: 970-1.

Haseman JK , Seilkop SK An examination of the association between maximum-tolerated dose and carcinogenicity in 326 long-term studies in rats and mice. Fund Appl Toxicol 1992; 19: 207-13.

Butterworth BE , Conolly RB , Morgan KT A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments . Cancer Lett 1995; 93: 129-46.

Clayson DB , Clegg DJ

Classification of carcinogens: Polemics, pedantics, or progress. Reg

Pharmacol Toxicol 1991; 14: 147-66.

Krewski D. , Gaylor DW , Soms AP , Szyszkowicz M. An overview of the report: Correlation between carcinogenic potency and the maximum tolerated dose: Implications for risk assessment. Risk Analysis 1993; 13: 383-97.

Ashby J. et al. Evaluation of the potential carcinogenicity and genetic toxicity to humans of the herbicide acetochlor. Hum Exp Toxicol 1994; 15: 702-735.

Wilson Age et al. Mechanism of the rat-specific nasal tumours observed with alachlor . Int Toxicologist 1995; 7: 45P-39 (Abstract).

10.

Davies TS , Monro A. The rodent carcinogenicity bioassay produces a similar frequency of tumor increases and decreases: Implications for risk assessment. Reg Pharmacol Toxicol 1994; 20: 281-301.